Analyses / ORCL
Large-cap enterprise software. Strong margins, solid growth, high valuation. Today -1.85%; recent analyst upgrade noted.
A free account reveals ORCL's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
EPS growth 24% YoY; 5Y revenue CAGR 10.7%; operating margin 30.6% (excellent); 25.4% net margin. Dividend yield 1.7%, payout ratio sustainable at 34%. Insider buys outnumber sells 54–83 over recent period. Forward P/E 20x reasonable for 10%+ growth profile. Cloud/AI tailwinds (Oracle Cloud, GenAI adoption) remain structural.
▼ Bear Case
P/E 20x, P/S 5.1x, EV/EBITDA 20.1x — all premium to historical and large-cap peers. Price-to-FCF 29x signals high expectations already priced in. Beta 1.75 (high volatility). Week52 high 346 vs. current 118 shows massive drawdown; no material news catalyst visible yet. Insider sells (83) still outnumber buys (54), net negative signal.
Valuation
FAIRLY PRICED with upside optionality — score 62/100
Forward P/E 20x is reasonable for a 24% EPS growth and 10% revenue growth profile. P/S 5.1x and EV/EBITDA 20x sit above historical mean but justified by margin quality (30.6% operating, 25.4% net). Price-to-FCF 29x is stretched, implying limited buffer. The 66% drawdown from 52-week high creates technical opportunity, but no intrinsic-value margin-of-safety yet apparent.
Technical Levels
Support · $116.20 (Today's intraday low; near-term floor) · $114.50 (52-week low; major support) · $110.00 (Round number & historical retracement target)
Resistance · $121.92 (Today's intraday high; immediate ceiling) · $130.00 (Breakout level; unlock further upside) · $150.00 (Medium-term target; recovery milestone)
RSI: Data unavailable
Financial Health
Score 68/100. Liquidity ratios (current 1.1, quick 1.0) adequate but not robust; suggests tight working capital or high short-term obligations. Debt, interest coverage, and long-term solvency data missing. Low tangible book value (5.65 vs. price 117.74) typical for intangible-heavy tech. Recommend checking SEC filings for full debt picture and FCF sustainability.
Catalysts
| Q4 FY2024 Earnings (likely Feb–Mar 2025) | 8–12 weeks | Highest relevance. Watch for Oracle Cloud revenue growth rate, margins, and forward guidance. Beat could reignite bull case; miss would validate bear thesis. |
| AI/GenAI Announcements (product launches, customer wins) | Ongoing; next likely conference or earnings call | Medium. Market hungry for evidence Oracle is capturing AI workloads. Concrete wins (e.g., major cloud customer migration to Oracle Cloud AI) could reset growth expectations. |
| Macro / Fed Rate Outlook | Continuous | Medium. Rising rates pressure growth-stock valuations; falling rates could re-rate ORCL higher. Beta 1.75 means ORCL moves 1.75x market swings. |
| Activist / M&A Activity | Unlikely near-term; speculative | Low-medium. ORCL size ($339B market cap) limits M&A optionality, but buyback or dividend hike could support stock. |
Risk Flags
See ORCL's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock ORCL free →Recent News
- Oracle: Bears May Pay A Big Price (Rating Upgrade)SeekingAlpha
- Oracle (ORCL) Stock Looks Undervalued On Earnings While Risks Still WeighYahoo
- Why Oracle (ORCL) Dipped More Than Broader Market TodayYahoo
- 3 Out-of-Favor Stocks We Keep Off Our RadarYahoo
- NVDA, NBIS, SKHY, SNDK Stock Losses Reportedly Force Ex-OpenAI Researcher's $20B Fund To Seek CapitalYahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full ORCL analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
ORCL FAQ
Is ORCL a buy right now?
Oracle Corp's current read is a Value with Growth Mix setup with 65 confidence over a 3–6 months horizon. Valuation: FAIRLY PRICED with upside optionality. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is ORCL overvalued?
FAIRLY PRICED with upside optionality (valuation score 62/100). Forward P/E 20x is reasonable for a 24% EPS growth and 10% revenue growth profile. P/S 5.1x and EV/EBITDA 20x sit above historical mean but justified by margin quality (30.6% operating, 25.4% net). Price-to-FCF 29x is stretched, implying limited buffer. The 66% drawdown from 52-week high creates technical opportunity, but no intrinsic-value margin-of-safety yet apparent.
What are the risks of buying ORCL?
P/E 20x, P/S 5.1x, EV/EBITDA 20.1x — all premium to historical and large-cap peers. Price-to-FCF 29x signals high expectations already priced in. Beta 1.75 (high volatility). Week52 high 346 vs. current 118 shows massive drawdown; no material news catalyst visible yet. Insider sells (83) still outnumber buys (54), net negative signal.